Europe Pharmaceutical Drugs Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Chronic Diseases

 

Europe Pharmaceutical Drugs Market 

Market Overview:

The Europe pharmaceutical drugs market deals with manufacturing and distribution of prescription and OTC drugs used for treating chronic and acute diseases prevalent across Europe. Key products in this market include drugs for treating cardiovascular diseases, cancer, diabetes, respiratory diseases, immunological diseases and CNS disorders. Pharmaceutical drugs enable improved quality of life by controlling symptoms, slowing disease progression and managing health conditions.

Market Dynamics:
The Europe pharmaceutical drugs market is being driven by rising prevalence of various chronic diseases such as cancer, cardiovascular diseases and diabetes. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of mortality in Europe, responsible for over 4 million deaths annually. Moreover, increasing geriatric population in European countries is also contributing to high incidence of chronic ailments, thereby propelling market growth.

Another factor promoting the Europe pharmaceutical drugs market growth is heavy investments in R&D by major players for development of novel drugs and therapies. For instance, Pfizer Inc. invested US$ 8 billion in R&D during 2019, while Roche invested US$ 11.7 billion. Ongoing clinical trials and new drug approvals are also boosting market revenues. However, risks of drug failures and stringent regulations for drug approval are some of the challenges faced by market players.

SWOT Analysis
Strength: Europe Pharmaceutical Drugs Market Share has strong presence of leading pharmaceutical companies and manufactures. The region has highly skilled workforce and advanced infrastructure for drug development. Stringent regulations ensure safety and efficacy of drugs.
Weakness: High development and manufacturing costs of drugs make the drugs expensive. Supply chain disruption due to COVID-19 pandemic affected the production and distribution of drugs in the region.
Opportunity: Growing geriatric population increases the demand for chronic ailments treatment drugs. Emergence of biosimilars provides cost-effective treatment options for patients.
Threats: Patent expiration of blockbuster drugs and introduction of generics erode the sales and market share of incumbent companies. Stringent regulations for approval delay market entry of new drugs.

Key Takeaways
The global Europe pharmaceutical drugs market is expected to witness high growth, exhibiting CAGR of 4.5% over the forecast period, due to increasing prevalence of chronic diseases. Chronic diseases such as cancer, diabetes, cardiovascular diseases are major health burden requiring long term medicinal treatment.

Regional analysis
Germany dominates the Europe pharmaceutical drugs market owing to presence of leading drug manufacturers. Germany accounted for over 20% of market share in 2023. UK pharmaceutical drugs market is expected to grow at fastest pace during forecast period supported by increasing healthcare spending and demand for specialty medicines.

Key players
Key players operating in the Europe pharmaceutical drugs market are Allergan plc. (A subsidiary of AbbVie Inc.), Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, GSK plc., AstraZeneca., Baxter, Novartis AG, F. Hoffmann-La Roche Limited, Shire (A subsidiary of Takeda Pharmaceutical Company Limited) and Sanofi. The key players focus on new drug development and product launches to strengthen their product portfolio and market share.

For more insights, Read- https://www.pressreleasebulletin.com/europe-pharmaceutical-drugs-market-size-and-share/

Comments

Post a Comment

Popular posts from this blog

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million adul
Read more

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the majo
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more